 Amen Sergew
Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Noninvasive Ventilation | 3 | 2021 | 31 | 1.550 |
Why?
| | Respiratory Insufficiency | 4 | 2022 | 286 | 1.420 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2020 | 60 | 0.680 |
Why?
| | Hypereosinophilic Syndrome | 1 | 2016 | 9 | 0.530 |
Why?
| | Pulmonary Eosinophilia | 1 | 2016 | 25 | 0.520 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2016 | 41 | 0.510 |
Why?
| | Drug Design | 2 | 2015 | 147 | 0.490 |
Why?
| | Molecular Targeted Therapy | 1 | 2015 | 347 | 0.420 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2015 | 501 | 0.330 |
Why?
| | Abdominal Pain | 1 | 2009 | 134 | 0.310 |
Why?
| | Solitary Fibrous Tumor, Pleural | 1 | 2008 | 3 | 0.300 |
Why?
| | Osteoarthropathy, Secondary Hypertrophic | 1 | 2008 | 4 | 0.300 |
Why?
| | Shock, Septic | 1 | 2009 | 185 | 0.290 |
Why?
| | Edema | 1 | 2008 | 119 | 0.280 |
Why?
| | Radiography, Thoracic | 1 | 2008 | 150 | 0.280 |
Why?
| | Privacy | 1 | 2022 | 28 | 0.200 |
Why?
| | Police | 1 | 2022 | 30 | 0.200 |
Why?
| | Airway Management | 1 | 2021 | 59 | 0.180 |
Why?
| | Home Care Services | 1 | 2021 | 219 | 0.150 |
Why?
| | Critical Care | 1 | 2020 | 472 | 0.130 |
Why?
| | Medicare | 1 | 2021 | 661 | 0.130 |
Why?
| | Diagnosis, Differential | 2 | 2009 | 1331 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 907 | 0.110 |
Why?
| | Humans | 10 | 2022 | 114080 | 0.110 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 2012 | 28 | 0.100 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2012 | 49 | 0.090 |
Why?
| | Arthritis, Experimental | 1 | 2011 | 130 | 0.090 |
Why?
| | Paracentesis | 1 | 2009 | 6 | 0.080 |
Why?
| | Disease Progression | 1 | 2015 | 2371 | 0.080 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 321 | 0.080 |
Why?
| | Acute Lung Injury | 1 | 2011 | 268 | 0.080 |
Why?
| | Respiration, Artificial | 1 | 2012 | 528 | 0.080 |
Why?
| | Prone Position | 2 | 2022 | 27 | 0.070 |
Why?
| | Prognosis | 1 | 2015 | 3315 | 0.070 |
Why?
| | Wnt Proteins | 1 | 2008 | 134 | 0.070 |
Why?
| | Lung Diseases, Interstitial | 1 | 2011 | 495 | 0.070 |
Why?
| | Arthritis, Rheumatoid | 1 | 2011 | 1006 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2011 | 3499 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2009 | 2764 | 0.050 |
Why?
| | Smartphone | 1 | 2022 | 73 | 0.050 |
Why?
| | Lung Diseases | 1 | 2008 | 690 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2021 | 51 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2022 | 327 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2273 | 0.040 |
Why?
| | Animals | 3 | 2015 | 31570 | 0.040 |
Why?
| | Patient Participation | 1 | 2021 | 348 | 0.040 |
Why?
| | Patient Selection | 1 | 2021 | 629 | 0.040 |
Why?
| | Oxygen | 1 | 2022 | 851 | 0.040 |
Why?
| | Hospitals | 1 | 2022 | 581 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 2008 | 2159 | 0.030 |
Why?
| | Adult | 2 | 2022 | 30395 | 0.030 |
Why?
| | Signal Transduction | 1 | 2008 | 4501 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2021 | 1381 | 0.030 |
Why?
| | Diterpenes | 1 | 2012 | 31 | 0.020 |
Why?
| | Supine Position | 1 | 2012 | 32 | 0.020 |
Why?
| | Lung Compliance | 1 | 2011 | 47 | 0.020 |
Why?
| | I-kappa B Proteins | 1 | 2012 | 80 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2011 | 271 | 0.020 |
Why?
| | Smoke | 1 | 2011 | 123 | 0.020 |
Why?
| | Bleomycin | 1 | 2011 | 228 | 0.020 |
Why?
| | Down-Regulation | 1 | 2012 | 594 | 0.020 |
Why?
| | Lung | 2 | 2012 | 3521 | 0.020 |
Why?
| | Collagen | 1 | 2011 | 414 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 1143 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2011 | 580 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 990 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 802 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1144 | 0.020 |
Why?
| | Middle Aged | 1 | 2008 | 26621 | 0.020 |
Why?
| | Female | 2 | 2011 | 59349 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2182 | 0.020 |
Why?
| | Male | 2 | 2012 | 55420 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1519 | 0.020 |
Why?
| | United States | 1 | 2021 | 12144 | 0.020 |
Why?
| | Rats | 1 | 2012 | 4913 | 0.010 |
Why?
| | Mice | 1 | 2011 | 14847 | 0.010 |
Why?
|
|
Sergew's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|